PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Osaka International Cancer Institute today announced that they have formed an alliance to advance clinical development in Japan. The partnership …
( read original story …)


Related Post

PV Gas D sells nearly 25 percent of stake to Tokyo...
views 142
PV Gas D sells nearly 25 percent of stake to Tokyo...
Japanese government deletes online report about Ka...
views 218
Online document was drafted by expert group to pro...
Killer fire ants INVASION: Warning over global spr...
views 112
More than 500 ants were found at Yokohama last mon...
Japanese airline forces disabled man to crawl aboa...
views 153
Japan's Vanilla Air has apologised after a wheelch...
Business leaders program highlights Hawaii-Hiroshi...
views 136
A new program by the Honolulu Japanese Chamber of ...
Japan logs 1% growth in 2016
views 204
Japan's economy expanded at a steadily slowing pac...
Moderate earthquake: M5 quake has struck near Chic...
views 101
A moderate earthquake with magnitude 5 (ml/mb) was...
Dentsu’s Nagoya branch hit with order to halt over...
views 156
Dentsu Inc.’s branch office in Nagoya receiv...
Japan tax agency head quits amid cronyism scandal
views 70
TOKYO (Reuters) - Japan's National Tax Agency chie...
Japan's Toshiba fights Western Digital over c...
views 203
Japanese electronics maker Toshiba is facing resis...